Chronic wounds are a silent epidemic.
Millions of people worldwide live with wounds that refuse to heal, disrupting lives, straining caregivers, and overwhelming healthcare systems. Aethl Bio exists to change how healing is defined and delivered.
A global problem, hiding in plain sight.
Chronic wounds are increasing as populations age and chronic disease becomes more prevalent, yet care models have failed to keep pace.
1 in 6
Medicare beneficiaries
suffers from a chronic wound
$148B+
Annual U.S.
healthcare costs
1 in 5
Diabetic foot ulcers
results in amputation
A Wound that Won't Heal: The Global Call for Robust Chronic Wound Care
Health is the utmost priority for every human being. Yet, treatment for common chronic wounds, which can have mortality rates comparable to cancer, has long gone neglected by modern healthcare systems. While nations spend billions each year trying to mitigate its public health burden, chronic wound prevalence is projected to only increase with time.
Chronic wounds affect far more than skin.
Patients often experience prolonged pain, reduced mobility, and social isolation, while families and caregivers shoulder the burden of long‑term care. Non‑healing wounds quietly erode independence, dignity, and quality of life—sometimes for years.
The system treats closure, not recovery
When underlying skin function is not restored, wounds are more likely to invite infection, rehospitalization, and life‑altering complications. Without approaches that prioritize functional healing, patients remain trapped in cycles of incomplete recovery.
Rethinking wound healing from the ground up
At Aethl Bio, we believe true healing restores function, not just appearance.
Our work is grounded in science, guided by patient needs, and focused on long-term outcomes.
Patient-Centered
Care designed around real‑world patient and caregiver needs
Science-Driven
Built on advances in wound biology and healing science
Function-Focused
Prioritizing durable recovery and restored skin integrity
Aethl Bio Appoints Dr. Joseph Maroon to Scientific Advisory Board, Strengthening Clinical and Scientific Leadership
Aethl Bio announces the appointment of Dr. Joseph Maroon, MD, FACS, to its Scientific Advisory Board. A renowned neurosurgeon, UPMC professor, and expert in oxygen-based therapies, Dr. Maroon brings deep clinical insight that will help advance the company’s platform and support the continued evolution of its next-generation wound care and wellness solutions.
Read Story
We're advancing the future of wound care through science, compassion, and purpose.
Aethl Bio is building solutions for a future where chronic wounds no longer define lives or limit potential. By re‑examining how healing is measured and supported, we aim to reduce recurrence, complications, and long‑term burden across the healthcare system. We invite visionary partners and clinical innovators to join us in accelerating these breakthroughs and setting a new standard for restorative care.